[1] ELANGO J, ZHANG J, BAO B, et al. Rheological, biocompatibility and osteogenesis assessment of fish collagen scaffold for bone tissue engineering. Int J Biol Macromol. 2016;91:51-59.
[2] SABURI E, ISLAMI M, HOSSEINZADEH S, et al. In vitro osteogenic differentiation potential of the human induced pluripotent stem cells augments when grown on Graphene oxide-modified nanofibers. Gene. 2019;696:72-79.
[3] ABAZARI MF, SOLEIMANIFAR F, ENDERAMI SE, et al. Incorporated-bFGF polycaprolactone/polyvinylidene fluoride nanocomposite scaffold promotes human induced pluripotent stem cells osteogenic differentiation. J Cell Biochem. 2019;120(10): 16750-16759.
[4] MONTECINO M, STEIN G, STEIN J, et al. Multiple levels of epigenetic control for bone biology and pathology. Bone. 2015;81:733-738.
[5] OTHMAN Z, FERNANDES H, GROOT AJ, et al. The role of ENPP1/PC-1 in osteoinduction by calcium phosphate ceramics. Biomaterials. 2019;210:12-24.
[6] LI X, GUO L, LIU Y, et al. MicroRNA-21 promotes osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1/5/8-Runx2 pathway. Biochem Biophys Res Commun. 2017;493(2):928-933.
[7] BAGLÌO SR, DEVESCOVI V, GRANCHI D, et al. MicroRNA expression profiling of human bone marrow mesenchymal stem cells during osteogenic differentiation reveals Osterix regulation by miR-31. Gene. 2013;527(1):321-331.
[8] ZHOU Z, LU Y, WANG Y, et al. Let-7c regulates proliferation and osteo-differentiation of human adipose-derived mesenchymal stem cells under oxidative stress by targeting SCD-1. American Journal of Physiology-Cell Physiology. 2018; 316(1):57-69.
[9] JIN T, LU Y, HE QX, et al. The Role of MicroRNA, miR-24, and Its Target CHI3L1 in Osteomyelitis Caused by Staphylococcus aureus. J Cell Biochem. 2015;116(12):2804-2813.
[10] LIAN JB, STEIN GS, VAN WIJNEN AJ, et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol.2012;8(4):212-227.
[11] VOLINIA S, CROCE CM. Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci U S A. 2013;110(18):7413-7417.
[12] BARTEL DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281-297.
[13] REN X, TUO Q, TIAN K, et al. Enhancement of osteogenesis using a novel porous hydroxyapatite scaffold in vivo and vitro. Ceramics International. 2018;44(17):21656-21665.
[14] LI J, ZHI W, XU T, et al. Ectopic osteogenesis and angiogenesis regulated by porous architecture of hydroxyapatite scaffolds with similar interconnecting structure in vivo. Regen Biomater. 2016;3(5): 285-297.
[15] 温永梅,牟雁东,伍佳,等.新型多孔羟基磷灰石陶瓷支架在骨内成骨的初步评价[J].中国口腔种植学杂志,2017,22(1):9-12,28.
[16] CHEN J, ULERICH JP, ABELEV E, et al. An investigation of the initial attachment and orientation of osteoblast-like cells on laser grooved Ti-6Al-4V surfaces. Materials Science and Engineering: C. 2009; 29(4):1442-1452.
[17] ENGELMAYR GC JR, PAPWORTH GD, WATKINS SC, et al. Guidance of engineered tissue collagen orientation by large-scale scaffold microstructures. J Biomech. 2006;39(10):1819-1831.
[18] HATA A, KANG H. Functions of the bone morphogenetic protein signaling pathway through microRNAs (review). Int J Mol Med. 2015; 35(3):563-568.
[19] KANG H, HATA A. The role of microRNAs in cell fate determination of mesenchymal stem cells: balancing adipogenesis and osteogenesis. BMB Rep. 2015;48(6):319-323.
[20] ARFAT Y, XIAO WZ, AHMAD M, et al. Role of microRNAs in osteoblasts differentiation and bone disorders. Curr Med Chem. 2015;22(6):748-758.
[21] KOMORI T. Roles of Runx2 in Skeletal Development. Adv Exp Med Biol. 2017;962:83-93.
[22] ULUDAG H, GAO T, PORTER TJ, et al. Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Joint Surg Am. 2001;83-A Suppl 1(Pt 2):S128-135.
[23] ZHAO YP, TIAN QY, FRENKEL S, et al. The promotion of bone healing by progranulin, a downstream molecule of BMP-2, through interacting with TNF/TNFR signaling. Biomaterials. 2013;34(27):6412-6421.
[24] CHANG N, GE J, XIU L, et al. HuR mediates motility of human bone marrow-derived mesenchymal stem cells triggered by sphingosine 1-phosphate in liver fibrosis. J Mol Med (Berl). 2017;95(1):69-82.
[25] ESKILDSEN T, TAIPALEENMÄKI H, STENVANG J, et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A. 2011; 108(15):6139-6144.
[26] SUGATANI T, HRUSKA KA. MicroRNA-223 is a key factor in osteoclast differentiation. J Cell Biochem. 2007;101(4):996-999.
[27] HU B, LI Y, WANG M, et al. Functional reconstruction of critical-sized load-bearing bone defects using a Sclerostin-targeting miR-210-3p-based construct to enhance osteogenic activity. Acta Biomater. 2018;76:275-282.
[28] MIZUNO Y, TOKUZAWA Y, NINOMIYA Y, et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett. 2009;583(13):2263-2268.
[29] GIANNAKAKIS A, SANDALTZOPOULOS R, GRESHOCK J, et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther. 2008;7(2):255-264.
[30] KONG Y, CHEN ZT. MiR-146a regulates osteogenic differentiation and proliferation of bone marrow stromal cells in traumatic femoral head necrosis. Eur Rev Med Pharmacol Sci. 2019;23(2):441-448.
[31] WU H, FAN H, SHOU Z, et al. Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1. Int Immunopharmacol. 2019;68:204-212.
[32] MATYSIAK M, FORTAK-MICHALSKA M, SZYMANSKA B, et al. MicroRNA-146a negatively regulates the immunoregulatory activity of bone marrow stem cells by targeting prostaglandin E2 synthase-2. J Immunol. 2013;190(10):5102-5109.
[33] LI C, YANG L, REN X, et al. Groove structure of porous hydroxyapatite scaffolds (HAS) modulates immune environment via regulating macrophages and subsequently enhances osteogenesis.J Biol Inorg Chem. 2019;24(5):733-745.
|